NCT02664961 2019-07-23
Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)
Tracon Pharmaceuticals Inc.
Phase 2 Terminated
Tracon Pharmaceuticals Inc.
Tracon Pharmaceuticals Inc.
AstraZeneca
Eli Lilly and Company